2 papers
stat.ME2026
Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
Sidi Wang, Kelley Kidwell, Bo Huang +1
Overall survival (OS) is the gold standard for assessing patient benefit and cost-effectiveness of new cancer drugs. However, it is often difficult to use OS as the primary endpoin…
stat.AP2025
Statistical Design and Rationale of the Biomarkers for Evaluating Spine Treatments (BEST) Trial
John Sperger, Kelley M. Kidwell, Matthew C. Mauck +16
Chronic low back pain (cLBP) is a prevalent condition with profound impacts on functioning and quality of life. While multiple evidence-based treatments exist, they all have modest…